AlphaQuest’s Annovis Bio ANVS Stock Holding History

AlphaQuest’s Portfolio ANVS Stock Details ANVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q4	–	Sell	-46,002	Closed	-$371K	–	1696
2024 Q3	$371K	Buy	+46,002	New	+$431K	0.03%	799
2024 Q2	–	Sell	-3,340	Closed	-$39.7K	–	1569
2024 Q1	$39.7K	Buy	+3,340	New	+$36.4K	0.01%	957

Other funds holding ANVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Citadel Advisors Miami, Florida $875B AUM 40.91% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

MFG

Merit Financial Group Alpharetta, Georgia $16.4B AUM 25.17% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $1.28T AUM 58.89% 1-Year Est. Return

CSS

Cubist Systematic Strategies Stamford, Connecticut $21B AUM 21.48% 1-Year Est. Return

UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return

WFAG

Wescott Financial Advisory Group Philadelphia, Pennsylvania $1.29B AUM 21.04% 1-Year Est. Return

AlphaQuest's ANVS Position: Q4 2024 in Review

AlphaQuest sold out of Annovis Bio (ANVS) in Q4 2024, closing a stake of 46,002 shares — an estimated $371K sold.

AlphaQuest first reported a position in ANVS in Q1 2024 and held it in 2 quarters. The position peaked at $371K in Q3 2024. 40 funds tracked by Wall St. Rank hold ANVS as of Q4 2024.

AlphaQuest reported no remaining Annovis Bio position as of Q4 2024 after selling out during the quarter.
AlphaQuest sold 46,002 Annovis Bio shares in Q4 2024, an estimated $371K.
AlphaQuest first reported a position in Annovis Bio in Q1 2024 and held it in 2 quarters.
AlphaQuest's Annovis Bio position peaked at $371K in Q3 2024.
40 funds tracked by Wall St. Rank held Annovis Bio as of Q4 2024.

Based on AlphaQuest's 13F filing for Q4 2024, filed 7 Feb 2025.